Update: BioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent
MT Newswires
Mon, February 23, 2026 at 8:01 PM GMT+9 1 min read
In this article:
BNTX
-0.25%
MRNA
+0.34%
(Updates with Moderna’s response in the fifth paragraph.) BioNTech (BNTX) sued rival Moderna (MRN
PREMIUM
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Upgrade
Already have a subscription? Sign in
Terms and Privacy Policy
Privacy Dashboard
More Info
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Update: BioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent
PREMIUM
Update: BioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent
MT Newswires
Mon, February 23, 2026 at 8:01 PM GMT+9 1 min read
In this article:
BNTX
-0.25%
MRNA
+0.34%
(Updates with Moderna’s response in the fifth paragraph.) BioNTech (BNTX) sued rival Moderna (MRN
PREMIUM
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Upgrade
Already have a subscription? Sign in
Terms and Privacy Policy
Privacy Dashboard
More Info